Endothelium-Specific Cre Recombinase Activity in flk-1-Cre Transgenic Mice

Developmental Dynamics

Volumn 229, Issue 2, 2004, Pages 312-318

  Licht, Alexander H ^a   Raab, Sabine ^a   Hofmann, Ursula ^a   Breier, Georg ^a,b  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b Institute for Pathology   (Germany)

Author keywords

Cre recombinase; Endothelium; Flk 1 promoter enhancer; Transgenic mice; Tumor vessel; Vascular development

Indexed keywords

BETA GALACTOSIDASE; CRE RECOMBINASE; VASCULOTROPIN RECEPTOR 2;

ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CELL TYPE; CORONARY BLOOD VESSEL; CROSS BREEDING; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUSION; GENE INACTIVATION; GENE TARGETING; GENETIC RECOMBINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ARTIFICIAL GENE FUSION; CELL LINE, TUMOR; EMBRYO; ENDOTHELIUM; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; INTEGRASES; LAC OPERON; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VIRAL PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0942276447     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.10416     Document Type: Article

References (29)

1. Akagi K, Sandig V, Vooijs M, Van der Valk M, Giovannini M, Strauss M, Berns A. 1997. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res 25:1766-1773.
2. Betz UA, Vosshenrich CA, Rajewsky K, Muller W. 1996. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination. Curr Biol 6:1307-1316.
3. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. 1998. A common precursor for hematopoietic and endothelial cells. Development 125:725-732.
4. Chung YS, Zhang WJ, Arentson E, Kingsley PD, Palis J, Choi K. 2002. Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development 129:5511-5520.
5. Condorelli G, Borello U, De Angelis L, Latronico M, Sirabella D, Coletta M, Galli R, Balconi G, Follenzi A, Frati G, Cusella De Angelis MG, Gioglio L, Amuchastegui S, Adorini L, Naldini L, Vescovi A, Dejana E, Cossu G. 2001. Cardiomyocytes induce endothelial cells to transdifferentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A 98:10733-10738.
6. De Angelis L, Berghella L, Coletta M, Lattanzi L, Zanchi M, Cusella-De Angelis MG, Ponzetto C, Cossu G. 1999. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 147:869-878.
7. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-de Groot AC. 1997. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 80:444-451.
8. Frid MG, Kale VA, Stenmark KR. 2002. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 90:1189-1196.
9. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. 1998. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest 78:1385-1394.
10. Gustafsson E, Brakebusch C, Hietanen K, Fassler R. 2001. Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci 114:671-676.
11. Hafner M, Orosz P, Kruger A, Mannel DN. 1996. TNF promotes metastasis by impairing natural killer cell activity. Int J Cancer 66:388-392.
12. Heidenreich R, Kappel A, Breier G. 2000. Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (Flk-1) promoter/enhancer sequences. Cancer Res 60:6142-6147.
13. Hirai H, Ogawa M, Suzuki N, Yamamoto M, Breier G, Mazda O, Imanishi J, Nishikawa S. 2003. Hemogenic and nonhemogenic endothelium can be distinguished by the activity of fetal liver kinase (Flk)-1 promoter/enhancer during mouse embryogenesis. Blood 101:886-893.
14. Hogan B, Beddington R, Costantini F, Lacy E. 1994. Manipulating the mouse embryo: a laboratory manual. New York: Cold Spring Harbor Laboratory Press.
15. Kabrun N, Buhring HJ, Choi K, Ullrich A, Risau W, Keller G. 1997. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124:2039-2048.
16. Kappel A, Ronicke V, Damert A, Flamme I, Risau W, Breier G. 1999. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood 93:4284-4292.
17. Kataoka H, Takakura N, Nishikawa S, Tsuchida K, Kodama H, Kunisada T, Risau W, Kita T, Nishikawa SI. 1997. Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells. Dev Growth Differ 39:729-740.
18. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. 2001. Tle2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230:230-242.
19. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A. 1994. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-579.
20. Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Moller NP, Risau W, Ullrich A. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculo-genesis and angiogenesis. Cell 72:835-846.
21. Minasi MG, Riminucci M, De Angelis L, Borello U, Berarducci B, Innocenzi A, Caprioli A, Sirabella D, Baiocchi M, De Maria R, Boratto R, Jaffredo T, Broccoli V, Bianco P, Cossu G. 2002. The mesoangioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129:2773-2783.
22. Motoike T, Markham DW, Rossant J, Sato TN. 2003. Evidence for novel fate of Flk1 + progenitor: contribution to muscle lineage. Genesis 35:153-159.
23. Nagy A. 2000. Cre recombinase: the universal reagent for genome tailoring. Genesis 26:99-109.
24. Risau W, Flamme I. 1995. Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91.
25. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
26. Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, Schwartz L, Bernstein A, Rossant J. 1997. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:981-990.
27. Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71.
28. Yamaguchi TP, Dumont D, Conlon RA, Breitman ML, Rossant J. 1993. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118:489-498.
29. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K. 2000. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.